APT Medical Inc. (SHA:688617)

China flag China · Delayed Price · Currency is CNY
243.10
-5.63 (-2.26%)
Apr 28, 2026, 3:00 PM CST
-18.60%
Market Cap 34.19B
Revenue (ttm) 2.72B
Net Income (ttm) 866.92M
Shares Out 140.64M
EPS (ttm) 6.13
PE Ratio 39.67
Forward PE 30.81
Dividend 1.00 (0.40%)
Ex-Dividend Date Jun 19, 2025
Volume 1,008,147
Average Volume 973,970
Open 248.10
Previous Close 248.73
Day's Range 241.50 - 251.74
52-Week Range 219.48 - 337.20
Beta -0.26
RSI 41.58
Earnings Date Apr 24, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addit... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 3,118
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688617
Full Company Profile

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.

Financial Statements

News

There is no news available yet.